Medical Devices

German company gets U.S. patent for artificial heart insert method, device

Published in Blood Weekly, September 30th, 2004

The patent (U.S. Patent No 6,764,508) claims a method for inserting an implant, such as a biological or artificial heart valve, into the human organism, as well as a special device for carrying out this method.

The basic term of the patent will expire in September 2019. Patents covering this technology are pending in other major markets, including Europe, Japan and Canada and have been issued in Australia and Singapore earlier this year.

The patent is a part of an intellectual property portfolio co.don AG has acquired some time ago. It builds the base for expanding the company's tissue engineering technologies into the area of cardiovascular...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2004-09-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry